Case Study: a major pharma commercial company identifies GvHD market opportunities and forecasts a game-changer asset with GlobalData

Major Pharma Commercial Company - Customer Case Study

GlobalData was engaged by a major pharma commercial company that needed to identify and prioritize unmet needs in the GvHD treatment landscape. The client also sought to devise a strategy for clinical adoption and to assess the market potential for a potential "game changer" asset in this space.

To address this, GlobalData leveraged its in-house disease experts to segment the market and identify key opportunities. The vendor also designed and executed a large online survey with stem cell transplant center physicians to gain insights into current treatment regimens. As a result, GlobalData delivered a prioritized list of opportunities by patient segment and geography, helped the client define the target product profile for a high-impact asset, and provided a forecast of its commercial potential.